多个系统缩中的自主功能障碍:从病理生理学到临床表现
Yuqi Luo1, Nan Yang2, Wanlin Yang1
1Department of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Annals of medicine
|July 28, 2025
概括
多重系统缩 (MSA) 导致自主功能障碍,原因是中枢神经系统中的α-synuclein沉积物. 本综述详细介绍了MSA的临床病理相关性和病理生理机制.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 自主神经系统障碍 自主神经系统障碍
背景情况:
- 多重系统缩 (MSA) 是一种致命的神经退行性疾病,其特征是缩在寡细胞中的α-synuclein.
- 由于相互连接的神经网络中的α-synuclein沉积,MSA导致早期和严重的自主功能障碍.
- 受影响的中枢神经系统区域包括下丘脑,脑干和脊髓,导致正静性低血压和膀功能障碍等症状.
研究的目的:
- 审查和总结MSA中自主功能障碍的临床病理相关性.
- 专注于MSA中各种自主功能障碍背后的病理生理机制.
- 详细阐述与MSA中的特定病理结构相关的临床表现.
主要方法:
- 文献综述和对MSA现有研究的综合.
- 对临床病理学数据的分析,将α-synuclein沉积与自主功能障碍相关联.
- 讨论与MSA病理生理学有关的神经成像和生理学研究.
主要成果:
- 在MSA中,自主功能障碍涉及中枢神经系统控制心血管,泌尿,生殖和胃肠功能.
- 中枢神经系统中的特定病理结构被确定为MSA相关自主症状的关键贡献者.
- 该综述强调了α-synuclein病理和自主神经系统损伤之间的复杂相互作用.
结论:
- 在MSA中自主功能障碍是广泛的中枢神经系统病理的复杂表现.
- 目前对MSA生理学和病理生理学的理解需要进一步阐明.
- 为了充分了解MSA的病变发生和临床相关性,进一步的研究至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
01:18Disorders of the Autonomic Nervous System
826
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
826
01:20Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
01:28Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
01:15Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
01:26Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K